<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23502" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Female Infertility</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Walker</surname>
            <given-names>Matthew H.</given-names>
          </name>
          <aff>Cape Fear Valley Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tobler</surname>
            <given-names>Kyle J.</given-names>
          </name>
          <aff>Womack Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew Walker declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kyle Tobler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23502.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Infertility is a medical condition that can cause psychological, physical, mental, spiritual, and medical detriments to the patient. The unique quality of this medical condition involves affecting both the patient and the patient's partner as a couple. Although male infertility is an important part of any infertility discussion, this&#x000a0;topic reviews the evaluation, management, and treatment of female infertility. To understand infertility, one must understand normal fecundability, the probability of achieving pregnancy in one menstrual cycle. This activity reviews the evaluation, management, and treatment of female infertility and highlights the interprofessional healthcare team's role in improving care for this patient population.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of female infertility.</p></list-item><list-item><p>Evaluate the most common findings of female infertility.</p></list-item><list-item><p>Determine how best to manage female infertility.</p></list-item><list-item><p>Communicate the importance of improving healthcare coordination among the interprofessional team to enhance and improve outcomes for female patients with infertility.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23502&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23502">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23502.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Infertility is a medical condition that can cause psychological, physical, mental, spiritual, and medical detriments to the patient. The unique quality of this medical condition involves affecting both the patient and the patient's partner as a couple. Although male infertility is an important part of any infertility discussion, this&#x000a0;topic reviews the evaluation, management, and treatment of female infertility. To understand infertility, one must understand normal fecundability, the probability of achieving pregnancy in&#x000a0;1 menstrual cycle. This basic understanding helps the healthcare team properly counsel the patient on referrals and provide basic education and understanding of this medical condition.&#x000a0;</p>
        <p>The research community has established a fecundability rate multiple times, which has helped establish normal pregnancy rates to assist in diagnosing infertility. The largest study identified that 85% of women would conceive within 12 months. Based on this study's findings, fecundability is 25% in the first&#x000a0;3 months of unprotected intercourse and then decreased to 15% for the remaining&#x000a0;9 months.<xref ref-type="bibr" rid="article-23502.r1">[1]</xref>&#x000a0;This research has helped the American Society of Reproductive Medicine (ASRM) establish when a couple should undergo an infertility evaluation.&#x000a0;The ASRM recommends initiating an evaluation for infertility after failing to achieve pregnancy within 12 months of unprotected intercourse or therapeutic donor insemination in women younger than 35 years or within 6 months in women older than 35.<xref ref-type="bibr" rid="article-23502.r2">[2]</xref></p>
      </sec>
      <sec id="article-23502.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The World Health Organization (WHO) performed a large multinational study to determine gender distribution and infertility etiologies. In 37% of infertile couples, female infertility was the cause; in 35% of couples, both male and female causes were identified; in 8%, there was male factor infertility.<xref ref-type="bibr" rid="article-23502.r3">[3]</xref> In the same study, the most common identifiable factors of female infertility are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Ovulatory disorders:</bold> 25%</p>
          </list-item>
          <list-item>
            <p><bold>Endometriosis:</bold> 15%</p>
          </list-item>
          <list-item>
            <p><bold>Pelvic adhesions:</bold> 12%</p>
          </list-item>
          <list-item>
            <p><bold>Tubal blockage:</bold> 11%</p>
          </list-item>
          <list-item>
            <p><bold>Other tubal/uterine abnormalities:</bold> 11%</p>
          </list-item>
          <list-item>
            <p><bold>Hyperprolactinemia:</bold> 7%</p>
          </list-item>
        </list>
        <p>These causes&#x000a0;are further investigated in later portions of this topic; male and unknown factors are outside the scope of this&#x000a0;topic.&#x000a0;Even though these factors are not discussed here, it is important to realize that male factor infertility represents a substantial portion of the identifiable factors causing infertility.</p>
      </sec>
      <sec id="article-23502.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In a study conducted by the National Survey of Family Growth that interviewed 12,000 women in the United States, the prevalence of infertility decreased with the increase in the woman&#x02019;s age.<xref ref-type="bibr" rid="article-23502.r4">[4]</xref>&#x000a0;As a woman gets older, her chances of infertility increase. In women aged 15 to 34 years, infertility rates ranged from 7.3% to 9.1%. In women ages 35 to 39 years old, the infertility rates increased to 25%. Lastly, women from ages 40 to 44 years had a 30% chance of infertility.<xref ref-type="bibr" rid="article-23502.r4">[4]</xref> Worldwide, infertility rates are higher in Eastern Europe, North Africa, and the Middle East.&#x000a0;Worldwide, 2% of women aged 20 to 44 were never able to have a live birth, and 11% with a previous live birth were unable to have an additional birth.<xref ref-type="bibr" rid="article-23502.r5">[5]</xref></p>
      </sec>
      <sec id="article-23502.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Anovulation</bold>
</p>
        <p>Ovulatory disorders make up 25% of the known causes of female infertility. Oligo-ovulation or anovulation results in infertility because no oocyte&#x000a0;are released monthly. Without an oocyte, there is no opportunity for fertilization and pregnancy. To help with treatment and further classification, the World Health Organization subdivided ovulatory disorders into&#x000a0;4 classes:</p>
        <list list-type="order">
          <list-item>
            <p><bold>Hypogonadotropic hypogonadal anovulation:</bold> Hypothalamic amenorrhea</p>
          </list-item>
          <list-item>
            <p><bold>Normogonadotropic normoestrogenic anovulation:</bold> Polycystic ovarian syndrome (PCOS)</p>
          </list-item>
          <list-item>
            <p><bold>Hypergonadotropic hypoestrogenic anovulation:</bold> Premature ovarian failure</p>
          </list-item>
          <list-item>
            <p><bold>Hyperprolactinemic anovulation:</bold> Pituitary adenoma</p>
          </list-item>
        </list>
        <p>Hypothalamic amenorrhea or functional hypothalamic amenorrhea (FHA) is associated with eating disorders and excessive exercise, which results in a decrease in hypothalamic GnRH secretion.<xref ref-type="bibr" rid="article-23502.r6">[6]</xref>&#x000a0;The decreased caloric intake, associated weight loss, or excessive exercise leads to elevated cortisol, which causes a suppression of GnRH.<xref ref-type="bibr" rid="article-23502.r7">[7]</xref> The decreased or absent pulsatility of GnRH results in a decrease in the release of gonadotropins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH) from the anterior pituitary gland. These&#x000a0;2 deficiencies result in abnormal follicle growth, anovulation, and low estrogen levels.<xref ref-type="bibr" rid="article-23502.r8">[8]</xref>&#x000a0;The FSH and LH have variations ranging from normal to low, but the hormone ratio resembles a prepubertal female, with FSH higher than LH.<xref ref-type="bibr" rid="article-23502.r8">[8]</xref>&#x000a0;</p>
        <p>The most common type of Normogonadotropic normoestrogenic anovulation is PCOS. PCOS accounts for 80% to 85% of all anovulatory patients and affects 8% of all reproductive-aged females.<xref ref-type="bibr" rid="article-23502.r9">[9]</xref>&#x000a0;PCOS can be diagnosed using the Rotterdam criteria, which requires at least&#x000a0;2 of the&#x000a0;3 below-listed criteria in the absence of other pathological causes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Oligoovulation/anovulation</p>
          </list-item>
          <list-item>
            <p>Clinical signs of hyperandrogenism or serological elevations of androgens</p>
          </list-item>
          <list-item>
            <p>Polycystic ovaries demonstrated with ultrasound&#x000a0;<xref ref-type="bibr" rid="article-23502.r10">[10]</xref></p>
          </list-item>
        </list>
        <p>Infertility caused by PCOS is thought to be associated with a dysfunction in developing a mature follicle, leading to anovulation. The FSH and estrogen&#x000a0;are be within normal laboratory limits. The LH can either be normal or elevated. The pathophysiology behind PCOS and infertility is not well understood; classically, abnormal pulsatility of GnRH is described as a possible underlying cause. Correlating the high number of arrested follicles and polycystic-appearing ovaries is the elevation of the anti-Mullerian hormone (AMH).<xref ref-type="bibr" rid="article-23502.r11">[11]</xref>&#x000a0;</p>
        <p>Hypergonadotropic hypoestrogenic anovulation is the category of premature ovarian insufficiency and ovarian resistance associated with females' age. As mentioned before, a woman&#x02019;s age affects fertility due to a well-studied phenomenon of a steady decline in the quality and quantity of the patient&#x02019;s oocytes. In quantity, the female fetus at 20 weeks gestation has roughly 6 million follicles. The newborn has approximately 1 million follicles. At the onset of puberty, the number of follicles decreases to 300,000.<xref ref-type="bibr" rid="article-23502.r12">[12]</xref> The rate of follicle loss continues throughout a woman&#x02019;s life and increases in rate around her mid-thirties.<xref ref-type="bibr" rid="article-23502.r13">[13]</xref> External factors are also associated with decreased follicular quantity. The most notable and highly researched is cigarette smoking. Fecundability and follicular quantity are both inversely proportional to the amount of cigarette smoking. Early menopause (under 40 years old) is also associated with cigarette smoking; there is a more than 30% increase in early menopause among ever-smokers.<xref ref-type="bibr" rid="article-23502.r14">[14]</xref></p>
        <p>Ovarian quality is also essential to overall fertility. The loss of the oocyte quality throughout a woman&#x02019;s life is associated with meiotic nondisjunction, resulting in aneuploidy. This is thought to be related to accumulated damage throughout life and age-related changes in the granulosa cells.<xref ref-type="bibr" rid="article-23502.r15">[15]</xref>&#x000a0;As women age, there is a significant increase in the number of meiotic nondisjunction events and corresponding aneuploid or chromosomally abnormal oocytes and embryos.<xref ref-type="bibr" rid="article-23502.r15">[15]</xref></p>
        <p>Primary ovarian insufficiency (POI) is defined as hypergonadotropic hypogonadism before the age of 40. This disease is characterized by a lack of folliculogenesis, a decrease in estrogen, loss of oocytes, and infertility.<xref ref-type="bibr" rid="article-23502.r16">[16]</xref> The most common cause of POI is Turner syndrome, monosomy of the sex chromosomes leading to a 45X karyotype.<xref ref-type="bibr" rid="article-23502.r17">[17]</xref>&#x000a0;Further discussion of Turner syndrome is outside the scope of this manuscript.&#x000a0;</p>
        <p>As mentioned above, the WHO recognizes prolactinemia as a leading cause of female infertility; however, the ASRM recently published guidelines that the initial workup does not need to include prolactin.<xref ref-type="bibr" rid="article-23502.r2">[2]</xref>&#x000a0;Prolactin causes suppression of hypothalamic GnRH secretion, leading to a low LH, resulting in anovulation, corresponding oligomenorrhea, or amenorrhea. Prolactin serum values of 20&#x000a0;to 50 ng/mL cause insufficient progesterone release from the corpus luteum, which shortens the luteal phase. Although controversial, prolactinemia is described as an etiology of luteal phase defects leading to infertility. Prolactin values of 50&#x000a0;to 100 ng/mL cause amenorrhea or oligomenorrhea due to abnormal feedback on the hypothalamic-pituitary-ovarian axis. A concentration greater than 100 ng/mL is associated with overt hypogonadism and amenorrhea and is most commonly associated with pituitary adenomas.<xref ref-type="bibr" rid="article-23502.r18">[18]</xref>&#x000a0;</p>
        <p>
<bold>Endometriosis</bold>
</p>
        <p>Endometriosis is defined as endometrial tissue outside the uterine cavity. The diagnosis is based on the histological identification of endometrial glands or stroma outside the uterus. Endometriosis is most commonly found in the pelvis but can spread throughout the entire abdomen and affects 10% to 15% of reproductive-age women.<xref ref-type="bibr" rid="article-23502.r19">[19]</xref> Of women with endometriosis, 40% to 50% experience infertility.<xref ref-type="bibr" rid="article-23502.r20">[20]</xref> Endometriosis is categorized into 4 stages, according to the American Society of Reproductive Medicine, with stage I being minimal and stage IV severe. Endometriosis is known to cause infertility, but the pathophysiology is thought to change according to the stage.<xref ref-type="bibr" rid="article-23502.r21">[21]</xref> For stages I and II, infertility is believed to be associated with inflammation and increased production of prostaglandins and cytokines, macrophages, and natural killer cells. <xref ref-type="bibr" rid="article-23502.r22">[22]</xref> The inflammation impairs ovarian and tubal function, resulting in defective follicular formation, fertilization, and implantation.<xref ref-type="bibr" rid="article-23502.r23">[23]</xref> Stages III and IV are associated with pelvic adhesions or masses that distort pelvic anatomy; this inherently impairs tubal motility, oocyte release, and sperm motility.<xref ref-type="bibr" rid="article-23502.r24">[24]</xref> Also, advanced endometriosis is hypothesized to impair folliculogenesis, reducing fertilization potential.<xref ref-type="bibr" rid="article-23502.r25">[25]</xref>&#x000a0;</p>
        <p>
<bold>Pelvic/Tubal Adhesions</bold>
</p>
        <p>Pelvic and tubal adhesions, along with uterine and tubal abnormalities, account for a large portion of female infertility. Infectious processes within the abdomen are the leading cause of pelvic/tubal adhesions; the most common infectious process to affect infertility is pelvic inflammatory disease (PID). The microorganism that carries the greatest risk of infertility in association with PID is <italic toggle="yes">Chlamydia trachomatis</italic>. One in 4 women with tubal factor infertility&#x000a0;has positive antibodies to chlamydia, which are inversely proportional to pregnancy rates.<xref ref-type="bibr" rid="article-23502.r26">[26]</xref> The number of PID episodes and the severity play a role in the likelihood of infertility.&#x000a0;One study demonstrated that the pregnancy rates following PID were 89% after 1 episode, 77% after two episodes, and 46% after&#x000a0;3 episodes.<xref ref-type="bibr" rid="article-23502.r27">[27]</xref> Regarding PID severity of mild, moderate, and severe, the live-birth rates were 90%, 82%, and 57%, respectively.<xref ref-type="bibr" rid="article-23502.r28">[28]</xref></p>
        <p>Hydrosalpinges, are a tubal abnormality caused by acute and chronic inflammation that damages the structural integrity of the fallopian. This damage leads to tubal obstruction, which blocks the distribution&#x000a0;of physiologic fluid in the fallopian tube and results in fluid accumulation. The belief is that hydrosalpinges impair fertility through the retrograde flow of toxins and prostaglandins into the endometrium, creating a hostile environment for implantation by impairing endometrial receptivity.<xref ref-type="bibr" rid="article-23502.r29">[29]</xref>&#x000a0;The literature has demonstrated that patients undergoing in-vitro fertilization have a 50% decrease in pregnancy if a hydrosalpinx is present.<xref ref-type="bibr" rid="article-23502.r30">[30]</xref></p>
        <p>
<bold>Uterine Causes</bold>
</p>
        <p>Uterine causes of infertility are associated with either space-occupying lesions or reduced endometrial receptivity. In regards to uterine leiomyomas (fibroids),&#x000a0;1 meta-analysis&#x000a0;demonstrated that only submucosal or intracavitary fibroids impaired implantation and pregnancy rates compared to other infertile controls.<xref ref-type="bibr" rid="article-23502.r31">[31]</xref> Congenital uterine abnormalities (CUA), although rare, are also associated with infertility. Most commonly found are uterine septums, which are also associated with recurrent pregnancy loss. Interestingly,&#x000a0;one study demonstrated that the prevalence of CUA in the fertile and infertile population is the same.<xref ref-type="bibr" rid="article-23502.r32">[32]</xref>&#x000a0;Infertility due to CUA is thought to account for roughly 8% of the female causes of infertility; however, 25% of women with late first-trimester or second-trimester miscarriages are found to have CUAs.<xref ref-type="bibr" rid="article-23502.r33">[33]</xref>&#x000a0;A detailed discussion of the classifications and pathophysiology of CUAs is outside the scope of this manuscript.</p>
      </sec>
      <sec id="article-23502.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Infertility evaluation is indicated in women with unsuccessful pregnancies after 12 months of unprotected regular intercourse or 6 months if they are over 35 years old.<xref ref-type="bibr" rid="article-23502.r34">[34]</xref> This&#x000a0;topic focuses on female infertility, but it is essential to remember that a male infertility evaluation is needed and should be initiated simultaneously. For women planning to use donor sperm, they should receive the same female infertility workup before inseminations.<xref ref-type="bibr" rid="article-23502.r2">[2]</xref> The key aspects of the history of the infertile woman are listed below:</p>
        <list list-type="bullet">
          <list-item>
            <p>Duration of infertility</p>
          </list-item>
          <list-item>
            <p>Obstetrical history</p>
          </list-item>
          <list-item>
            <p>Menstrual history, including molimina</p>
          </list-item>
          <list-item>
            <p>Medical, surgical, and gynecological history to include a history of sexually transmitted infections</p>
          </list-item>
          <list-item>
            <p>Sexual history to include coital frequency and timing
<list list-type="bullet"><list-item><p>Focusing on&#x000a0;the male partner, which includes issues with erection and ejaculation</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Social and lifestyle history to include cigarettes, alcohol, and illicit drug use, exercise, and diet, occupation</p>
          </list-item>
          <list-item>
            <p>Family history, screening for genetic issues, history of venous thrombotic events, recurrent pregnancy loss, and infertility</p>
          </list-item>
        </list>
        <p>&#x000a0;The physical exam should include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vital signs and&#x000a0;body mass index</p>
          </list-item>
          <list-item>
            <p>Thyroid evaluation</p>
          </list-item>
          <list-item>
            <p>Breast exam for galactorrhea</p>
          </list-item>
          <list-item>
            <p>Signs of androgen excess: dermatological and external genitalia exam</p>
          </list-item>
          <list-item>
            <p>The appearance of abnormal vaginal or cervical anatomy</p>
          </list-item>
          <list-item>
            <p>Pelvic masses or tenderness</p>
          </list-item>
          <list-item>
            <p>Uterine enlargement or irregularity</p>
          </list-item>
          <list-item>
            <p>Transvaginal ultrasonography is often done at the bedside as part of the initial physical exam</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-23502.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The 5 diagnostic evaluation categories are:</p>
        <list list-type="order">
          <list-item>
            <p>Semen analysis</p>
          </list-item>
          <list-item>
            <p>Assessment of ovarian function and reserve</p>
          </list-item>
          <list-item>
            <p>Assessment of the uterine cavity</p>
          </list-item>
          <list-item>
            <p>Assessment of the fallopian tubes</p>
          </list-item>
          <list-item>
            <p>Endocrinological serum studies</p>
          </list-item>
        </list>
        <p>The evaluation and interpretation of a semen analysis are outside the scope of this review; however, the importance of this test as part of the initial evaluation before initiating treatments cannot be reiterated enough.</p>
        <p>Assessment of ovarian function can be as simple as the menstrual cycle history. Women with predictable, regular cycles and predictable menstrual flow and molimina (bloating, fatigue, breast tenderness) are more than likely ovulating. At-home urinary LH predictor kits detect a mid-cycle LH surge, which is indirect evidence of ovulation and helps identify the fertile window.<xref ref-type="bibr" rid="article-23502.r35">[35]</xref>&#x000a0;Ovulation can also be detected by a cycle day 21 progesterone serum level or, more accurately, a mid-luteal phase progesterone level. The lab should be taken approximately 1 week before menses, and a progesterone lab value greater than 3 ng/mL is evidence of ovulation.<xref ref-type="bibr" rid="article-23502.r36">[36]</xref> A more invasive, more accurate, but likely unnecessary means of determining ovulation is daily ultrasounds for following the growth and disappearance of a follicle.<xref ref-type="bibr" rid="article-23502.r37">[37]</xref></p>
        <p>There are multiple available tests to assess ovarian reserve, and this&#x000a0;topic only discusses the&#x000a0;2 most common: Cycle day 3 FSH and estradiol and Anti-Mullerian hormone (AMH). The theory of day 3 FSH and estradiol is that women with good ovarian reserve have early sufficient ovarian hormones from small follicles to allow FSH to remain lower. According to multiple examples in the literature, it is most important to identify women with a reduced follicle count that produces insufficient hormones, causing a lack of inhibition, resulting in an elevated FSH. FSH levels less than 10 IU/mL demonstrate likely normal ovarian reserve, 10 to 20 IU/mL is intermediate, and an FSH greater than 20 IU/mL is a poor prognosis for spontaneous ovulation due to low ovarian reserve. According to one&#x000a0;study, the pregnancy rates per natural menstrual cycle, corresponding to the FSH levels above, are 32%, 17% to 19%, and 3%.<xref ref-type="bibr" rid="article-23502.r38">[38]</xref> Day 3 estradiol less than 80 pg/mL is normal with adequate ovarian reserve. Values greater than 80 pg/mL resulted in lower pregnancy rates, and values &#x0003e;100 pg/mL had a 0% pregnancy rate.<xref ref-type="bibr" rid="article-23502.r39">[39]</xref></p>
        <p>AMH is a hormone expressed by preantral and antral follicles, representing a marker of ovarian function that can be measured at any time during a woman&#x02019;s cycle.<xref ref-type="bibr" rid="article-23502.r40">[40]</xref> The AMH levels gradually decline throughout a woman&#x02019;s natural reproductive life to undetectable levels at menopause.<xref ref-type="bibr" rid="article-23502.r41">[41]</xref> AMH levels seem to be a good predictor of exogenous gonadotropin response<xref ref-type="bibr" rid="article-23502.r42">[42]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Less than 0.5 ng/mL:</bold> Predicts difficulty getting more than 3 follicles to grow</p>
          </list-item>
          <list-item>
            <p><bold>Less than 1.0 ng/mL:</bold>&#x000a0;Shows limited egg supply that may require more aggressive ovulation induction protocols</p>
          </list-item>
          <list-item>
            <p><bold>1.0 to 3.5 ng/mL:</bold> Shows normal values</p>
          </list-item>
          <list-item>
            <p><bold>Greater than 3.5:</bold> Shows ample supply and may require mild induction to prevent ovarian hyperstimulation syndrome</p>
          </list-item>
        </list>
        <p>It is important to remember that the available ovarian reserve tests are reliable in predicting ovulation induction difficulties but are not diagnostic in predicting live births. They should not be used to exclude patients from in vitro fertilization (IVF) treatment.<xref ref-type="bibr" rid="article-23502.r43">[43]</xref>&#x000a0;</p>
        <p>Antral follicle counts, measuring the number of follicles less than 9mm in the ovaries with transvaginal ultrasound in the early follicular phase, is also an accurate measure of ovarian reserve and predictive of ovarian response to stimulation.<xref ref-type="bibr" rid="article-23502.r44">[44]</xref></p>
        <p>
<bold>Tubal Evaluation</bold>
</p>
        <p>The gold standard for the evaluation of tubal patency is laparoscopy with chromopertubation. Laparoscopy is indicated as a first-line diagnostic test for suspected pelvic adhesions, endometriosis, or other pelvic pathologies; however, due to high specificity and being less invasive, the hysterosalpingogram (HSG) is more commonly used for the first-line evaluation for tubal patency and abnormalities.<xref ref-type="bibr" rid="article-23502.r45">[45]</xref> The ability to detect abnormalities is best for proximal occlusion, followed by distal occlusions; however, the HSG has poor predictability for intrauterine and tubal adhesions.<xref ref-type="bibr" rid="article-23502.r46">[46]</xref> Another added benefit of the HSG is increased pregnancy and live birth rates with oil-soluble media. A meta-analysis showed that after HSG, pregnancy, and live birth rates increased compared to controls (overall response, 2.98; 95% CI 1.05-6.37).<xref ref-type="bibr" rid="article-23502.r47">[47]</xref>&#x000a0;</p>
        <p>
<bold>Uterine Cavity</bold>
</p>
        <p>The gold standard for assessing the uterine cavity is hysteroscopy, which allows direct visualization of the intrauterine pathology&#x000a0;and provides an opportunity for immediate surgical correction. Although hysteroscopy is considered the gold standard, a less invasive approach is more commonly utilized with a saline infusion sonogram (SIS). The SIS is highly sensitive and specific for all intrauterine abnormalities and is adequate as a screening tool before infertility treatment, with or without 3-D model rendering.<xref ref-type="bibr" rid="article-23502.r48">[48]</xref></p>
      </sec>
      <sec id="article-23502.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Lifestyle Changes</bold>
</p>
        <p>Women with extremes in body mass index (BMI) frequently present with infertility and ovulatory dysfunction.<xref ref-type="bibr" rid="article-23502.r49">[49]</xref> Women with a BMI of less than 17 kg/m^2 with a history of intense exercise regimens or women with eating disorders are likely to develop hypogonadotropic hypogonadism, which causes decreased pituitary gonadotropin secretions.<xref ref-type="bibr" rid="article-23502.r50">[50]</xref> In The United States, controlled ovarian stimulation using exogenous gonadotropins is used to induce ovulation; however, in Europe, women who fail to respond to therapy can receive pulsatile GnRH therapy.<xref ref-type="bibr" rid="article-23502.r51">[51]</xref> One study demonstrated the importance of behavioral change in inducing ovulation. Of the women who received individual-directed therapy to correct energy deficiencies or behavior problems, 87% resumed regular ovarian function to correct the abnormal BMI.<xref ref-type="bibr" rid="article-23502.r52">[52]</xref></p>
        <p>Women with a BMI greater than 27 kg/m^2 with anovulation can improve ovulation with weight loss alone. Multiple studies have shown that losing 10% of body weight restores normal ovulation in 50% to 100% of women in less than 1 year.<xref ref-type="bibr" rid="article-23502.r53">[53]</xref> Even though weight loss is important for many aspects of a patient's life, one study showed that obese women who received counseling and interventions for weight loss before infertility treatment did not have higher pregnancy or live birth rates compared to obese women who had infertility treatment without weight-loss interventions. Therefore, a specific BMI is not required to initiate fertility treatment.<xref ref-type="bibr" rid="article-23502.r54">[54]</xref></p>
        <p>
<bold>Controlled Ovarian Hyperstimulation</bold>
</p>
        <p>The first-line medication for infertility of unknown origin and the medication most providers&#x000a0;use is clomiphene citrate (CC). Clomiphene is a selective estrogen receptor modulator (SERM) with estrogen antagonists and agonist effects that ultimately increase gonadotropin release from the anterior pituitary. Clomiphene treats WHO class 2 anovulation effectively but is ineffective in WHO class 1 and class 3 anovulation. Clomiphene is dosed starting at 50mg starting on cycle days 2, 3, 4, or 5 for 5 sequential days. The couple is encouraged to have intercourse every other day for&#x000a0;1 week, beginning 5 days after the last pill. However, the odds of pregnancy may be increased when clomiphene is combined with intrauterine insemination (IUI). There is little difference in the results of ovulation, pregnancy, or live birth regarding which day the medication is started, between cycle days 2 to 5.<xref ref-type="bibr" rid="article-23502.r55">[55]</xref></p>
        <p>Another commonly used oral medication for ovulation induction is letrozole. Letrozole is an aromatase inhibitor that prevents estrogen production by preventing the conversion of androstenedione and testosterone to estrone and estradiol.<xref ref-type="bibr" rid="article-23502.r56">[56]</xref>&#x000a0;Letrozole is FDA-indicated for the extended adjuvant treatment of breast cancer, and its use for ovulation induction is considered off-label. However, an abundance of scientific literature and multiple committee opinions support both the efficacy and safety of its use in ovulation induction. Letrozole is dosed starting at 2.5, 5, or 7.5 mg/day on cycle days 3, 4, 5, 6, and 7, with intercourse every other day 5 days after completing the medication, which is similar to clomiphene. According to ACOG, letrozole should be considered the first-line treatment for women with PCOS over clomiphene.<xref ref-type="bibr" rid="article-23502.r57">[57]</xref> The benefits of letrozole over clomiphene are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Higher rate of monofollicular development and a corresponding decrease in twin gestations</p>
          </list-item>
          <list-item>
            <p>Shorter half-life</p>
          </list-item>
          <list-item>
            <p>No antiestrogenic effects on the endometrium and central nervous system</p>
          </list-item>
          <list-item>
            <p>Lower estradiol levels, which is a benefit for women with breast cancer undergoing IVF&#x000a0;</p>
          </list-item>
        </list>
        <p>Letrozole's beneficial profile compared to clomiphene may replace clomiphene as a first-line treatment.<xref ref-type="bibr" rid="article-23502.r58">[58]</xref></p>
        <p>Gonadotropin therapy is a more intensive medical regimen used for WHO Class 1, 2, or 3 anovulatory disorders. Gonadotropins are beneficial as a second-line treatment option for women who fail to conceive after multiple cycles of clomiphene. There is one study that showed an increased live birth rate with gonadotropins compared to continued clomiphene usage.<xref ref-type="bibr" rid="article-23502.r59">[59]</xref>&#x000a0;Multiple dosing protocols are used depending on the provider's preferences and on the infertility treatment decided. Those protocols are outside the scope of this review. However, it is important to discuss that close monitoring is required while using more invasive and intensive gonadotropins. To evaluate mature follicles, transvaginal ultrasounds are used to monitor follicular growth every 2 to 3 days during the late follicular phase. A mature follicle is over 18 mm in diameter, and estradiol levels are greater than 200 pg/mL. Once a mature follicle is identified, a 250 mg recombinant HCG subcutaneous injection or intramuscular injection of 10,000U of urinary-derived HCG is given to trigger ovulation.<xref ref-type="bibr" rid="article-23502.r60">[60]</xref> Once the trigger shot is given, an IUI occurs 24-36 hours later. IUIs can be used in combination with all ovarian induction agents, and IUI with medication is encouraged to increase pregnancy rates, which&#x000a0;is discussed below. There is unclear evidence as to the superiority of allowing a natural LH surge versus an HCG trigger before IUI. A meta-analysis completed in 2010 showed no clear evidence of&#x000a0;1 treatment option over the other, and the treatment choice should be based on cost, hospital staffing restrictions, and patient convenience.<xref ref-type="bibr" rid="article-23502.r61">[61]</xref>&#x000a0;</p>
        <p>
<bold>Tubal and Pelvic Adhesions&#x000a0;</bold>
</p>
        <p>In vitro fertilization (IVF) is the first-line treatment for bilateral tubal factor infertility. Tubal corrective surgeries have worse pregnancy outcomes and have an increased risk of ectopic pregnancy. Women with severe tubal disease, including hydrosalpinx, are encouraged to have a bilateral salpingectomy to increase the pregnancy rate of IVF.<xref ref-type="bibr" rid="article-23502.r62">[62]</xref> For women with mild distal tubal disease, fimbrioplasty is an option to allow for multiple pregnancies without IVF. One small study showed that the pregnancy rate was equal to IVF for mild tubal disease, but the risk of ectopic pregnancy was 15% compared to 0.7% for IVF treatment.<xref ref-type="bibr" rid="article-23502.r63">[63]</xref></p>
        <p>The patients with a prior bilateral salpingectomy or tubal ligation for contraception are an important tubal factor population. It is always important for healthcare providers to discuss the risk of regret with all women who desire tubal ligation. The chance of pregnancy after tubal reanastomosis depends on the patient's age, the type of ligation, and the tubal length available. Younger women who had a ring or a clip with more than 4 cm of tubal length are the best candidates and have comparable pregnancy rates to IVF.<xref ref-type="bibr" rid="article-23502.r64">[64]</xref>&#x000a0;However, the time to pregnancy is significantly longer following tubal surgery as compared to IVF.</p>
        <p>
<bold>Uterine Abnormalities</bold>
</p>
        <p>There is unclear evidence on the effect of leiomyomas on infertility and live birth rates. It is recommended that the patient receive a complete infertility workup before further investigation into fibroids. The most important aspect of fibroids is the location. Fibroids that impinge on the endometrium and distort the uterine cavity result in impaired implantation and increased miscarriage rates.<xref ref-type="bibr" rid="article-23502.r65">[65]</xref> Women with submucosal or submucosal-intramural fibroids that distort the uterine cavity have been proven to have decreased pregnancy rates. With the removal of these fibroids, pregnancy, and live birth rates increase.<xref ref-type="bibr" rid="article-23502.r66">[66]</xref> The first-line treatment for the removal of the most detrimental fibroids is operative hysteroscopy. Other uterine pathologies like uterine synechiae and septa are more related to recurrent pregnancy loss but are capable of causing infertility. Operative hysteroscopy has shown a marked reduction in pregnancy loss for women with both synechiae and septa.<xref ref-type="bibr" rid="article-23502.r67">[67]</xref>&#x000a0; Asymptomatic polyps have also been shown to cause infertility. One study showed a polypectomy on asymptomatic infertile women before IUI increased pregnancy rates from 28% to 63%.<xref ref-type="bibr" rid="article-23502.r68">[68]</xref>&#x000a0;</p>
        <p>
<bold>IVF Procedures</bold>
</p>
        <p>This section discusses an overview of IVF procedures without discussing medication protocols as the most effective treatment option for infertility. Step 1 is controlled ovarian hyperstimulation with injectable gonadotropins, most commonly. Thirty-six hours after a trigger shot or HCG injection, a specialist performs a transvaginal ultrasonography-guided needle aspiration and oocyte retrieval. After retrieval, the oocytes are transferred to a special media, and normal sperm is transferred to the dish for insemination. If there is abnormal sperm, intracytoplasmic sperm injection (ICSI) is performed. ICSI is a procedure that places a single spermatozoon directly into the egg cytoplasm. After fertilization, the embryo is assessed and graded. The embryos are then transferred on Day 3 or Day 5. Preimplantation genetic testing (PGT) is an additional IVF procedure that helps detect known parental genetic mutations or balanced translocation. PGT can also be used to detect aneuploidy, both monosomies and trisomies, from all 23 chromosome pairs. Apart from a known parental carrier for a genetic mutation or balanced translocation, PGT is likely beneficial for advanced maternal age, repeated IVF failures with high-grade embryos, recurrent pregnancy loss, and unexplained infertility.</p>
      </sec>
      <sec id="article-23502.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Infertility is a highly complex disorder with significant effects on the couple as a whole. It is important to remember that there can be, and regularly are, multiple causes of infertility. The differential diagnosis for infertility can be extensive, and a thorough workup is required to ensure no harmful disease process is missed. Due to the expansive nature of this discussion,&#x000a0;this topic focuses on the differential diagnosis of PCOS due to its high prevalence in the infertile population.&#x000a0;</p>
        <p>The differential diagnosis for patients with suspected PCOS includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Androgen-producing ovarian tumors</p>
          </list-item>
          <list-item>
            <p>Adrenal tumors</p>
          </list-item>
          <list-item>
            <p>Nonclassic congenital adrenal hyperplasia</p>
          </list-item>
          <list-item>
            <p>Cushing syndrome</p>
          </list-item>
          <list-item>
            <p>Prolactinemia disorders</p>
          </list-item>
          <list-item>
            <p>Thyroid disorders</p>
          </list-item>
        </list>
        <p>The investigation of PCOS should include total testosterone, DHEA-S, and 17-Hydroxyprogesterone for evaluation of a virilizing ovarian or adrenal tumor or nonclassical congenital adrenal hyperplasia (CAH). There is a suggestion that DHEA-S should only be reserved for women with severe virilization because an asymptomatic, slightly elevated DHEA-S level does not affect management. Additionally, prolactin and thyroid-stimulating hormones should be measured.</p>
        <list list-type="bullet">
          <list-item>
            <p>The upper limit of normal for female testosterone is 45 to 60 ng/dL.<xref ref-type="bibr" rid="article-23502.r69">[69]</xref></p>
          </list-item>
          <list-item>
            <p>A testosterone value greater than 150 ng/dL warrants investigation for ovarian and adrenal androgen-secreting tumors.<xref ref-type="bibr" rid="article-23502.r69">[69]</xref></p>
          </list-item>
          <list-item>
            <p>DHEA-S of greater than 500 to 700 mcg/dL warrants further investigation of an adrenal tumor.<xref ref-type="bibr" rid="article-23502.r70">[70]</xref></p>
          </list-item>
          <list-item>
            <p>A fasting 17-hydroxyprogesterone greater than 200 ng/dL collected during the follicular phase warrants an ACTH stimulation test, and a value greater than 500 ng/dL is diagnostic for nonclassical congenital adrenal hyperplasia.<xref ref-type="bibr" rid="article-23502.r71">[71]</xref></p>
          </list-item>
        </list>
        <p>The clinical signs and further evaluation of these disorders are outside the scope of this paper.</p>
      </sec>
      <sec id="article-23502.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>This section covers the pregnancy rates per cycle for each treatment modality. The data are mostly from evaluating unexplained infertility but are also consistent with known causes. The rates of IVF vary drastically according to multiple individual factors. The following pregnancy rates were&#x000a0;collected from a retrospective analysis of 45 separate studies:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>No treatment:</bold> 1.3% to 3.8%</p>
          </list-item>
          <list-item>
            <p><bold>IUI alone:</bold> 4%</p>
          </list-item>
          <list-item>
            <p><bold>Clomiphene citrate (CC) alone:</bold> 5.6%</p>
          </list-item>
          <list-item>
            <p><bold>CC with IUI:</bold> 8.3%</p>
          </list-item>
          <list-item>
            <p><bold>Gonadotropins alone:</bold> 7.7%</p>
          </list-item>
          <list-item>
            <p><bold>Gonadotropins with IUI:</bold> 17.1%</p>
          </list-item>
          <list-item>
            <p><bold>IVF:</bold> 20.7%&#x000a0;<xref ref-type="bibr" rid="article-23502.r72">[72]</xref></p>
          </list-item>
        </list>
        <p>Letrozole alone and letrozole with IUI result in similar pregnancy rates as CC plus IUI and can be used for women for who IVF is not an option and who have failed CC plus IUI.<xref ref-type="bibr" rid="article-23502.r73">[73]</xref></p>
        <p>In 2009, a study showed that women who failed CC plus IUI should go straight to IVF instead of gonadotropins plus IUI before IVF. This study resulted in less time to achieve pregnancy, fewer treatment cycles, and lower total financial cost per delivery.<xref ref-type="bibr" rid="article-23502.r74">[74]</xref> The IVF pregnancy rates have increased since the paper reported above; however, the data still proves that IVF results in the highest pregnancy rates of all treatment options.</p>
        <p>The research above suggests that providers can use clomiphene alone as a first-line treatment for infertility. This is no longer true. In 2008, a randomized control trial showed that clomiphene alone had lower live birth rates than expectant management, respectively 14% and 17%.<xref ref-type="bibr" rid="article-23502.r75">[75]</xref> This paper did show a benefit regarding patient satisfaction versus expectant management; however, most women in both categories were satisfied with their care. In light of this study, ASRM published a committee opinion stating that clomiphene with timed intercourse should be discouraged as a first-line treatment for unexplained infertility.<xref ref-type="bibr" rid="article-23502.r75">[75]</xref></p>
      </sec>
      <sec id="article-23502.s11" sec-type="Complications">
        <title>Complications</title>
        <p>The&#x000a0;3 primary complications associated with infertility treatments are multiples, ectopic pregnancy, and ovarian hyperstimulation syndrome.</p>
        <p>
<bold>Multiple Gestations</bold>
</p>
        <p>The risk of multiples has been a problem for artificial reproductive technologies since the practice's inception. In the US, 32% of assisted reproductive technology pregnancies were multiples compared to 3.4% of naturally conceived births.<xref ref-type="bibr" rid="article-23502.r76">[76]</xref>&#x000a0;In 2009, according to the Centers for Disease Control (CDC), the chances of singleton, twin, or higher-order pregnancies with IVF fresh embryo transfer were 62%, 29%, and 3%, respectively.<xref ref-type="bibr" rid="article-23502.r77">[77]</xref>&#x000a0;The oral ovarian induction agents, clomiphene and letrozole, have a lower risk of multiple gestations than gonadotropins, with the percentages of twins, triplets, and quadruplets of 7%, 0.5%, and 0.3%, respectively. Gonadotropins have a 13% chance of multiple gestations, including triplets.<xref ref-type="bibr" rid="article-23502.r78">[78]</xref>&#x000a0;</p>
        <p>Currently, the ASRM and CDC have strongly promoted the use of elective single embryo transfer (eSET) for good prognosis patients. With the use of eSET, the rates of twins and triplets dropped to less than 1%. Additionally, there is active debate about whether gonadotropins should be used for ovulation induction outside of an IVF protocol due to the high risk of multiples.<xref ref-type="bibr" rid="article-23502.r79">[79]</xref>&#x000a0;As the use of IVF increases, the use of gonadotropins in conjunction with IUI is likely to continue to decrease.</p>
        <p>
<bold>Ectopic Pregnancy</bold>
</p>
        <p>Ectopic pregnancy following treatment of infertile patients is another risk that requires extensive counseling. There is a two-to-threefold increase in ectopic pregnancies among infertility patients. This is thought to be associated with a high percentage of tubal factor infertility.<xref ref-type="bibr" rid="article-23502.r80">[80]</xref> The highest associated risk of ectopic pregnancy is after tubal surgery to correct tubal factor infertility. Rates of ectopic pregnancy following tubal reconstructive surgery are approximately 9%, with other reports as high as 30%.<xref ref-type="bibr" rid="article-23502.r63">[63]</xref> The risk of ectopic pregnancy with IVF fresh embryo transfer is higher than frozen embryo transfer, but the overall rate of ectopic pregnancies with IVF is roughly 1.3%.<xref ref-type="bibr" rid="article-23502.r81">[81]</xref> There does not seem to be an increase in ectopic pregnancies with the use of ovulation induction agents combined with IUI versus natural conception; however, in a large study comparing the ovulation induction agents, clomiphene, letrozole, and gonadotropins had ectopic pregnancy rates of 4%, 6%, and 8%, respectively.<xref ref-type="bibr" rid="article-23502.r82">[82]</xref>&#x000a0;</p>
        <p>
<bold>Ovarian Hyperstimulation Syndrome&#x000a0;</bold>
</p>
        <p>Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic complication of controlled ovarian hyperstimulation that results in a broad range of signs and symptoms, ranging from abdominal distention, nausea, vomiting, enlarged ovaries, third-spacing of fluids, renal failure, and venous thrombosis, acute respiratory distress syndrome, electrolyte derangements, cardiac arrhythmias, and sepsis. If severe OHSS is not treated and monitored, mortality can result from the listed complications. The different stages of OHSS were classified by Golan et al. in 1989.<xref ref-type="bibr" rid="article-23502.r83">[83]</xref> The underlying&#x000a0;pathophysiological feature is increased capillary permeability, resulting in a fluid shift into the third space. Women at the highest risk of developing OHSS are those patients with greater than 20 mature follicles who also receive an HCG trigger shot. The incidence of moderate and severe OHSS with IVF ranges from 6% to 1%, respectively.<xref ref-type="bibr" rid="article-23502.r84">[84]</xref> The diagnosis, prevention, and management of OHSS are outside the scope of this manuscript.</p>
      </sec>
      <sec id="article-23502.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Women should see their providers for a referral to an infertility subspecialist if they are unable to achieve pregnancy&#x000a0;after 1 year of unprotected timed intercourse or if she is older than 35 years of age, 6 months of unprotected timed intercourse.<xref ref-type="bibr" rid="article-23502.r2">[2]</xref> It is important to explain that infertility can result from&#x000a0;both female and male factors or a combination of the two. This is important to remember, as most couples with infertility seek care through the female partner's health provider, potentially overlooking the male contribution. The medications and procedures available for female infertility are well-studied and have a well-known risk profile. The patient needs to be aware of the risk of multiple gestations, ectopic pregnancy, and OHSS.&#x000a0;Finally, the patient needs to understand the odds of pregnancy per treatment cycle for each modality. The inability to conceive, even with IVF, is a possibility that needs to be fully understood before dedicating a large number of resources required for infertility treatment.</p>
      </sec>
      <sec id="article-23502.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>As mentioned at the beginning of this topic, infertility is a devastating diagnosis and should be&#x000a0;considered a disease process by all healthcare team members. The author believes the best way to improve the physical, emotional, social, and interpersonal stressors of infertility for the patient is to complete an immediate and thorough investigation into both partners. The evaluation is straightforward and can be completed before referral to a fertility subspecialist. This expedites and enhances the specialist's ability to initiate follow-up studies and treatments. The use of either clomiphene or letrozole with timed intercourse alone can be used to correct a known cause of anovulation but should not prolong the referral to a subspecialist. All primary care providers need to set realistic expectations of the chances of pregnancy and the possibility of complications when counseling couples suffering from infertility. Lastly, this manuscript is not all-encompassing but provides a basic foundation of knowledge to feel comfortable discussing a patient's family planning goals, initiating an evaluation, and reviewing available treatments.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-23502.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23502&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23502">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/female-infertility/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23502">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23502/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23502">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23502.s15">
        <title>References</title>
        <ref id="article-23502.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>GUTTMACHER</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Factors affecting normal expectancy of conception.</article-title>
            <source>J Am Med Assoc</source>
            <year>1956</year>
            <month>Jun</month>
            <day>30</day>
            <volume>161</volume>
            <issue>9</issue>
            <fpage>855</fpage>
            <page-range>855-60</page-range>
            <pub-id pub-id-type="pmid">13319020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <article-title>Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781.</article-title>
            <source>Obstet Gynecol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>133</volume>
            <issue>6</issue>
            <fpage>e377</fpage>
            <page-range>e377-e384</page-range>
            <pub-id pub-id-type="pmid">31135764</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <article-title>Recent advances in medically assisted conception. Report of a WHO Scientific Group.</article-title>
            <source>World Health Organ Tech Rep Ser</source>
            <year>1992</year>
            <volume>820</volume>
            <fpage>1</fpage>
            <page-range>1-111</page-range>
            <pub-id pub-id-type="pmid">1642014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chandra</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Copen</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Stephen</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Infertility and impaired fecundity in the United States, 1982-2010: data from the National Survey of Family Growth.</article-title>
            <source>Natl Health Stat Report</source>
            <year>2013</year>
            <month>Aug</month>
            <day>14</day>
            <issue>67</issue>
            <fpage>1</fpage>
            <page-range>1-18, 1 p following 19</page-range>
            <pub-id pub-id-type="pmid">24988820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mascarenhas</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Flaxman</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Boerma</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vanderpoel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>GA</given-names>
              </name>
            </person-group>
            <article-title>National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys.</article-title>
            <source>PLoS Med</source>
            <year>2012</year>
            <volume>9</volume>
            <issue>12</issue>
            <fpage>e1001356</fpage>
            <pub-id pub-id-type="pmid">23271957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Santoro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Filicori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crowley</surname>
                <given-names>WF</given-names>
              </name>
            </person-group>
            <article-title>Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone.</article-title>
            <source>Endocr Rev</source>
            <year>1986</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-23</page-range>
            <pub-id pub-id-type="pmid">3082615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ackerman</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Guereca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Herzog</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Cortisol secretory parameters in young exercisers in relation to LH secretion and bone parameters.</article-title>
            <source>Clin Endocrinol (Oxf)</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>78</volume>
            <issue>1</issue>
            <fpage>114</fpage>
            <page-range>114-9</page-range>
            <pub-id pub-id-type="pmid">22671919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perkins</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1999</year>
            <month>Jun</month>
            <volume>84</volume>
            <issue>6</issue>
            <fpage>1905</fpage>
            <page-range>1905-11</page-range>
            <pub-id pub-id-type="pmid">10372685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hull</surname>
                <given-names>MG</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>1</volume>
            <issue>3</issue>
            <fpage>235</fpage>
            <page-range>235-45</page-range>
            <pub-id pub-id-type="pmid">3140583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <collab>Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group</collab>
            <article-title>Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).</article-title>
            <source>Hum Reprod</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-7</page-range>
            <pub-id pub-id-type="pmid">14688154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fauser</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Van Heusden</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Manipulation of human ovarian function: physiological concepts and clinical consequences.</article-title>
            <source>Endocr Rev</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-106</page-range>
            <pub-id pub-id-type="pmid">9034787</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baker</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>Radiosensitivity of mammalian oocytes with particular reference to the human female.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1971</year>
            <month>Jul</month>
            <day>01</day>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>746</fpage>
            <page-range>746-61</page-range>
            <pub-id pub-id-type="pmid">4935165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Richardson</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Senikas</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1987</year>
            <month>Dec</month>
            <volume>65</volume>
            <issue>6</issue>
            <fpage>1231</fpage>
            <page-range>1231-7</page-range>
            <pub-id pub-id-type="pmid">3119654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westhoff</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Heller</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Predictors of ovarian follicle number.</article-title>
            <source>Fertil Steril</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>624</fpage>
            <page-range>624-8</page-range>
            <pub-id pub-id-type="pmid">11020495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broekmans</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Soules</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Fauser</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Ovarian aging: mechanisms and clinical consequences.</article-title>
            <source>Endocr Rev</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>465</fpage>
            <page-range>465-93</page-range>
            <pub-id pub-id-type="pmid">19589949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Anasti</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Kimzey</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Defensor</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Lipetz</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Shawker</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Merino</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>1470</fpage>
            <page-range>1470-5</page-range>
            <pub-id pub-id-type="pmid">7962345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Primary ovarian insufficiency.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Feb</month>
            <day>05</day>
            <volume>360</volume>
            <issue>6</issue>
            <fpage>606</fpage>
            <page-range>606-14</page-range>
            <pub-id pub-id-type="pmid">19196677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sepp&#x000e4;l&#x000e4;</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ranta</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirvonen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Hyperprolactinaemia and luteal insufficiency.</article-title>
            <source>Lancet</source>
            <year>1976</year>
            <month>Jan</month>
            <day>31</day>
            <volume>1</volume>
            <issue>7953</issue>
            <fpage>229</fpage>
            <page-range>229-30</page-range>
            <pub-id pub-id-type="pmid">55535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olive</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Pritts</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Treatment of endometriosis.</article-title>
            <source>N Engl J Med</source>
            <year>2001</year>
            <month>Jul</month>
            <day>26</day>
            <volume>345</volume>
            <issue>4</issue>
            <fpage>266</fpage>
            <page-range>266-75</page-range>
            <pub-id pub-id-type="pmid">11474666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prescott</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Farland</surname>
                <given-names>LV</given-names>
              </name>
              <name>
                <surname>Tobias</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Gaskins</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Spiegelman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chavarro</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Rich-Edwards</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Barbieri</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Missmer</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>A prospective cohort study of endometriosis and subsequent risk of infertility.</article-title>
            <source>Hum Reprod</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>7</issue>
            <fpage>1475</fpage>
            <page-range>1475-82</page-range>
            <pub-id pub-id-type="pmid">27141041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Macer</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility.</article-title>
            <source>Obstet Gynecol Clin North Am</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>39</volume>
            <issue>4</issue>
            <fpage>535</fpage>
            <page-range>535-49</page-range>
            <pub-id pub-id-type="pmid">23182559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bulun</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Endometriosis.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Jan</month>
            <day>15</day>
            <volume>360</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-79</page-range>
            <pub-id pub-id-type="pmid">19144942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Aziz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Krajcir</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Agarwal</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pathogenic mechanisms in endometriosis-associated infertility.</article-title>
            <source>Fertil Steril</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>90</volume>
            <issue>2</issue>
            <fpage>247</fpage>
            <page-range>247-57</page-range>
            <pub-id pub-id-type="pmid">18672121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holoch</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Lessey</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Endometriosis and infertility.</article-title>
            <source>Clin Obstet Gynecol</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>429</fpage>
            <page-range>429-38</page-range>
            <pub-id pub-id-type="pmid">20436320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toya</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ohta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Saito</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kaneko</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hiroi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Moderate and severe endometriosis is associated with alterations in the cell cycle of granulosa cells in patients undergoing in vitro fertilization and embryo transfer.</article-title>
            <source>Fertil Steril</source>
            <year>2000</year>
            <month>Feb</month>
            <volume>73</volume>
            <issue>2</issue>
            <fpage>344</fpage>
            <page-range>344-50</page-range>
            <pub-id pub-id-type="pmid">10685541</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Joesoef</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hagdu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results.</article-title>
            <source>Sex Transm Dis</source>
            <year>1992</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>185</fpage>
            <page-range>185-92</page-range>
            <pub-id pub-id-type="pmid">1411832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Westr&#x000f6;m</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1980</year>
            <month>Dec</month>
            <day>01</day>
            <volume>138</volume>
            <issue>7 Pt 2</issue>
            <fpage>880</fpage>
            <page-range>880-92</page-range>
            <pub-id pub-id-type="pmid">7008604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lepine</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Hillis</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Marchbanks</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Joesoef</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Westrom</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Severity of pelvic inflammatory disease as a predictor of the probability of live birth.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1998</year>
            <month>May</month>
            <volume>178</volume>
            <issue>5</issue>
            <fpage>977</fpage>
            <page-range>977-81</page-range>
            <pub-id pub-id-type="pmid">9609570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Castelbaum</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Somkuti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sagoskin</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Lessey</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Hydrosalpinges adversely affect markers of endometrial receptivity.</article-title>
            <source>Hum Reprod</source>
            <year>1997</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>7</issue>
            <fpage>1393</fpage>
            <page-range>1393-8</page-range>
            <pub-id pub-id-type="pmid">9262264</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Voorhis</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Mejia</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Schlaff</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>Is removal of hydrosalpinges prior to in&#x000a0;vitro fertilization the standard of care?</article-title>
            <source>Fertil Steril</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>111</volume>
            <issue>4</issue>
            <fpage>652</fpage>
            <page-range>652-656</page-range>
            <pub-id pub-id-type="pmid">30929723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pritts</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Fibroids and infertility: a systematic review of the evidence.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>483</fpage>
            <page-range>483-91</page-range>
            <pub-id pub-id-type="pmid">11496160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grimbizis</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Camus</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tarlatzis</surname>
                <given-names>BC</given-names>
              </name>
              <name>
                <surname>Bontis</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Devroey</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Clinical implications of uterine malformations and hysteroscopic treatment results.</article-title>
            <source>Hum Reprod Update</source>
            <year>2001</year>
            <season>Mar-Apr</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>161</fpage>
            <page-range>161-74</page-range>
            <pub-id pub-id-type="pmid">11284660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>YY</given-names>
              </name>
              <name>
                <surname>Jayaprakasan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zamora</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thornton</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Raine-Fenning</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Coomarasamy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review.</article-title>
            <source>Hum Reprod Update</source>
            <year>2011</year>
            <season>Nov-Dec</season>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>761</fpage>
            <page-range>761-71</page-range>
            <pub-id pub-id-type="pmid">21705770</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine</collab>
            <article-title>Definitions of infertility and recurrent pregnancy loss: a committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>99</volume>
            <issue>1</issue>
            <fpage>63</fpage>
            <pub-id pub-id-type="pmid">23095139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility</collab>
            <article-title>Optimizing natural fertility.</article-title>
            <source>Fertil Steril</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>90</volume>
            <issue>5 Suppl</issue>
            <fpage>S1</fpage>
            <page-range>S1-6</page-range>
            <pub-id pub-id-type="pmid">19007604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wathen</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Perry</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lilford</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Chard</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range.</article-title>
            <source>Br Med J (Clin Res Ed)</source>
            <year>1984</year>
            <month>Jan</month>
            <day>07</day>
            <volume>288</volume>
            <issue>6410</issue>
            <fpage>7</fpage>
            <page-range>7-9</page-range>
            <pub-id pub-id-type="pmid">6418326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ecochard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boehringer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rabilloud</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marret</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Chronological aspects of ultrasonic, hormonal, and other indirect indices of ovulation.</article-title>
            <source>BJOG</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>108</volume>
            <issue>8</issue>
            <fpage>822</fpage>
            <page-range>822-9</page-range>
            <pub-id pub-id-type="pmid">11510707</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdalla</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thum</surname>
                <given-names>MY</given-names>
              </name>
            </person-group>
            <article-title>An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve.</article-title>
            <source>Hum Reprod</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>893</fpage>
            <page-range>893-8</page-range>
            <pub-id pub-id-type="pmid">15016786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smotrich</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Widra</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Gindoff</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Stillman</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Prognostic value of day 3 estradiol on in vitro fertilization outcome.</article-title>
            <source>Fertil Steril</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>1136</fpage>
            <page-range>1136-40</page-range>
            <pub-id pub-id-type="pmid">7589666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dewailly</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Andersen</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Balen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Broekmans</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Dilaver</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fanchin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Griesinger</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kelsey</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>La Marca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambalk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>The physiology and clinical utility of anti-Mullerian hormone in women.</article-title>
            <source>Hum Reprod Update</source>
            <year>2014</year>
            <season>May-Jun</season>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>370</fpage>
            <page-range>370-85</page-range>
            <pub-id pub-id-type="pmid">24430863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Vet</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laven</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Themmen</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Fauser</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <article-title>Antim&#x000fc;llerian hormone serum levels: a putative marker for ovarian aging.</article-title>
            <source>Fertil Steril</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>77</volume>
            <issue>2</issue>
            <fpage>357</fpage>
            <page-range>357-62</page-range>
            <pub-id pub-id-type="pmid">11821097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toner</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Seifer</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Why we may abandon basal follicle-stimulating hormone testing: a sea change in determining ovarian reserve using antim&#x000fc;llerian hormone.</article-title>
            <source>Fertil Steril</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>99</volume>
            <issue>7</issue>
            <fpage>1825</fpage>
            <page-range>1825-30</page-range>
            <pub-id pub-id-type="pmid">23548941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steiner</surname>
                <given-names>AZ</given-names>
              </name>
              <name>
                <surname>Pritchard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Stanczyk</surname>
                <given-names>FZ</given-names>
              </name>
              <name>
                <surname>Kesner</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Meadows</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Herring</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Baird</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.</article-title>
            <source>JAMA</source>
            <year>2017</year>
            <month>Oct</month>
            <day>10</day>
            <volume>318</volume>
            <issue>14</issue>
            <fpage>1367</fpage>
            <page-range>1367-1376</page-range>
            <pub-id pub-id-type="pmid">29049585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vrontikis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Kovacs</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lindheim</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Antral follice counts (AFC) predict ovarian response and pregnancy outcomes in oocyte donation cycles.</article-title>
            <source>J Assist Reprod Genet</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>383</fpage>
            <page-range>383-9</page-range>
            <pub-id pub-id-type="pmid">20467804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mol</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Swart</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bossuyt</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>van der Veen</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Is hysterosalpingography an important tool in predicting fertility outcome?</article-title>
            <source>Fertil Steril</source>
            <year>1997</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>663</fpage>
            <page-range>663-9</page-range>
            <pub-id pub-id-type="pmid">9093191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papaioannou</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bourdrez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Afnan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Coomarasamy</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Tubal evaluation in the investigation of subfertility: a structured comparison of tests.</article-title>
            <source>BJOG</source>
            <year>2004</year>
            <month>Dec</month>
            <volume>111</volume>
            <issue>12</issue>
            <fpage>1313</fpage>
            <page-range>1313-21</page-range>
            <pub-id pub-id-type="pmid">15663113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luttjeboer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Harada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hughes</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lilford</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Tubal flushing for subfertility.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2007</year>
            <month>Jul</month>
            <day>18</day>
            <issue>3</issue>
            <fpage>CD003718</fpage>
            <pub-id pub-id-type="pmid">17636730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seshadri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>El-Toukhy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Douiri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jayaprakasan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Khalaf</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic accuracy of saline infusion sonography in the evaluation of uterine cavity abnormalities prior to assisted reproductive techniques: a systematic review and meta-analyses.</article-title>
            <source>Hum Reprod Update</source>
            <year>2015</year>
            <season>Mar-Apr</season>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>262</fpage>
            <page-range>262-74</page-range>
            <pub-id pub-id-type="pmid">25505226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frisch</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>The right weight: body fat, menarche and ovulation.</article-title>
            <source>Baillieres Clin Obstet Gynaecol</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>419</fpage>
            <page-range>419-39</page-range>
            <pub-id pub-id-type="pmid">2282736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Rebar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vandenberg</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ehara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Siler</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pituitary gonadotrophin responsiveness to synthetic LRF in subjects with normal and abnormal hypothalamic-pituitary-gonadal axis.</article-title>
            <source>J Reprod Fertil Suppl</source>
            <year>1973</year>
            <month>Dec</month>
            <volume>20</volume>
            <issue>0</issue>
            <fpage>137</fpage>
            <page-range>137-61</page-range>
            <pub-id pub-id-type="pmid">4599401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abraham</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mira</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Llewellyn-Jones</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Should ovulation be induced in women recovering from an eating disorder or who are compulsive exercisers?</article-title>
            <source>Fertil Steril</source>
            <year>1990</year>
            <month>Mar</month>
            <volume>53</volume>
            <issue>3</issue>
            <fpage>566</fpage>
            <page-range>566-8</page-range>
            <pub-id pub-id-type="pmid">2407567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berga</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Loucks</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Hlastala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ringham</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Krohn</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Recovery of ovarian activity in women with functional hypothalamic amenorrhea who were treated with cognitive behavior therapy.</article-title>
            <source>Fertil Steril</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>80</volume>
            <issue>4</issue>
            <fpage>976</fpage>
            <page-range>976-81</page-range>
            <pub-id pub-id-type="pmid">14556820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crosignani</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Colombo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vegetti</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Somigliana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gessati</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ragni</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet.</article-title>
            <source>Hum Reprod</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>1928</fpage>
            <page-range>1928-32</page-range>
            <pub-id pub-id-type="pmid">12923151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mutsaerts</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>van Oers</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Groen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Burggraaff</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kuchenbecker</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Perquin</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Koks</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>van Golde</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kaaijk</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Schierbeek</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Oosterhuis</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Broekmans</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Bemelmans</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lambalk</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Verberg</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>van der Veen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Klijn</surname>
                <given-names>NF</given-names>
              </name>
              <name>
                <surname>Mercelina</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>van Kasteren</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Nap</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Brinkhuis</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Vogel</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Mulder</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Gondrie</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>de Bruin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sikkema</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>de Greef</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>ter Bogt</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Land</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Hoek</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Randomized Trial of a Lifestyle Program in Obese Infertile Women.</article-title>
            <source>N Engl J Med</source>
            <year>2016</year>
            <month>May</month>
            <day>19</day>
            <volume>374</volume>
            <issue>20</issue>
            <fpage>1942</fpage>
            <page-range>1942-53</page-range>
            <pub-id pub-id-type="pmid">27192672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Winkel</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>The effect of therapy initiation day on clomiphene citrate therapy.</article-title>
            <source>Fertil Steril</source>
            <year>1989</year>
            <month>Oct</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>564</fpage>
            <page-range>564-8</page-range>
            <pub-id pub-id-type="pmid">2806595</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cole</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Mechanism and inhibition of cytochrome P-450 aromatase.</article-title>
            <source>J Med Chem</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>11</issue>
            <fpage>2933</fpage>
            <page-range>2933-42</page-range>
            <pub-id pub-id-type="pmid">2231592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <article-title>ACOG Committee Opinion No. 738: Aromatase Inhibitors in Gynecologic Practice.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>131</volume>
            <issue>6</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">29794680</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casper</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Mitwally</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Review: aromatase inhibitors for ovulation induction.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>91</volume>
            <issue>3</issue>
            <fpage>760</fpage>
            <page-range>760-71</page-range>
            <pub-id pub-id-type="pmid">16384846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiss</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Nahuis</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bordewijk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oosterhuis</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Smeenk</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Hoek</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Broekmans</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Fleischer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>de Bruin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Kaaijk</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Laven</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Hendriks</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Gerards</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>van Rooij</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Bourdrez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gianotten</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koks</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lambalk</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hompes</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>van der Veen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>BWJ</given-names>
              </name>
              <name>
                <surname>van Wely</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.</article-title>
            <source>Lancet</source>
            <year>2018</year>
            <month>Feb</month>
            <day>24</day>
            <volume>391</volume>
            <issue>10122</issue>
            <fpage>758</fpage>
            <page-range>758-765</page-range>
            <pub-id pub-id-type="pmid">29273245</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ludwig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Doody</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Doody</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Use of recombinant human chorionic gonadotropin in ovulation induction.</article-title>
            <source>Fertil Steril</source>
            <year>2003</year>
            <month>May</month>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>1051</fpage>
            <page-range>1051-9</page-range>
            <pub-id pub-id-type="pmid">12738494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cantineau</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Janssen</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Cohlen</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Synchronised approach for intrauterine insemination in subfertile couples.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2010</year>
            <month>Apr</month>
            <day>14</day>
            <issue>4</issue>
            <fpage>CD006942</fpage>
            <pub-id pub-id-type="pmid">20393953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Mak</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sowter</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2004</year>
            <issue>3</issue>
            <fpage>CD002125</fpage>
            <pub-id pub-id-type="pmid">15266464</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Audebert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pouly</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Bonifacie</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Yazbeck</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Laparoscopic surgery for distal tubal occlusions: lessons learned from a historical series of 434 cases.</article-title>
            <source>Fertil Steril</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>102</volume>
            <issue>4</issue>
            <fpage>1203</fpage>
            <page-range>1203-8</page-range>
            <pub-id pub-id-type="pmid">25150389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boeckxstaens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Devroey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tournaye</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Getting pregnant after tubal sterilization: surgical reversal or IVF?</article-title>
            <source>Hum Reprod</source>
            <year>2007</year>
            <month>Oct</month>
            <volume>22</volume>
            <issue>10</issue>
            <fpage>2660</fpage>
            <page-range>2660-4</page-range>
            <pub-id pub-id-type="pmid">17670765</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pritts</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Olive</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Fibroids and infertility: an updated systematic review of the evidence.</article-title>
            <source>Fertil Steril</source>
            <year>2009</year>
            <month>Apr</month>
            <volume>91</volume>
            <issue>4</issue>
            <fpage>1215</fpage>
            <page-range>1215-23</page-range>
            <pub-id pub-id-type="pmid">18339376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Casini</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Agostini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Unfer</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Effects of the position of fibroids on fertility.</article-title>
            <source>Gynecol Endocrinol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>106</fpage>
            <page-range>106-9</page-range>
            <pub-id pub-id-type="pmid">16603437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>March</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Israel</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Gestational outcome following hysteroscopic lysis of adhesions.</article-title>
            <source>Fertil Steril</source>
            <year>1981</year>
            <month>Oct</month>
            <volume>36</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <page-range>455-9</page-range>
            <pub-id pub-id-type="pmid">6269905</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Medina</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bajo-Arenas</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salazar</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Redondo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sanfrutos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alvarez</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Engels</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study.</article-title>
            <source>Hum Reprod</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>1632</fpage>
            <page-range>1632-5</page-range>
            <pub-id pub-id-type="pmid">15760959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Milczarek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kucharska</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Borowiec</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Difficulties in diagnostics of polycystic ovary syndrome in adolescents - a preliminary study.</article-title>
            <source>Pediatr Endocrinol Diabetes Metab</source>
            <year>2019</year>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>122</fpage>
            <page-range>122-126</page-range>
            <pub-id pub-id-type="pmid">31769270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Derksen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nagesser</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Meinders</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Haak</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>van de Velde</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Identification of virilizing adrenal tumors in hirsute women.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>Oct</month>
            <day>13</day>
            <volume>331</volume>
            <issue>15</issue>
            <fpage>968</fpage>
            <page-range>968-73</page-range>
            <pub-id pub-id-type="pmid">8084355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Azziz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dewailly</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Owerbach</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Clinical review 56: Nonclassic adrenal hyperplasia: current concepts.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>1994</year>
            <month>Apr</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>810</fpage>
            <page-range>810-5</page-range>
            <pub-id pub-id-type="pmid">8157702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zolton</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lindner</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Terry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>DeCherney</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Hill</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Gonadotropins versus oral ovarian stimulation agents for unexplained infertility: a systematic review and meta-analysis.</article-title>
            <source>Fertil Steril</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>113</volume>
            <issue>2</issue>
            <fpage>417</fpage>
            <page-range>417-425.e1</page-range>
            <pub-id pub-id-type="pmid">31973903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Letrozole versus clomiphene citrate for unexplained infertility: a systematic review and meta-analysis.</article-title>
            <source>J Obstet Gynaecol Res</source>
            <year>2014</year>
            <month>May</month>
            <volume>40</volume>
            <issue>5</issue>
            <fpage>1205</fpage>
            <page-range>1205-16</page-range>
            <pub-id pub-id-type="pmid">24754848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Reindollar</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Regan</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Thornton</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Alper</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Goldman</surname>
                <given-names>MB</given-names>
              </name>
            </person-group>
            <article-title>A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial.</article-title>
            <source>Fertil Steril</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>888</fpage>
            <page-range>888-99</page-range>
            <pub-id pub-id-type="pmid">19531445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine</collab>
            <article-title>Use of clomiphene citrate in infertile women: a committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>100</volume>
            <issue>2</issue>
            <fpage>341</fpage>
            <page-range>341-8</page-range>
            <pub-id pub-id-type="pmid">23809505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sunderam</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kissin</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Folger</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Boulet</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Warner</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Callaghan</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Barfield</surname>
                <given-names>WD</given-names>
              </name>
            </person-group>
            <article-title>Assisted Reproductive Technology Surveillance - United States, 2016.</article-title>
            <source>MMWR Surveill Summ</source>
            <year>2019</year>
            <month>Apr</month>
            <day>26</day>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <page-range>1-23</page-range>
            <pub-id pub-id-type="pmid">31022165</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r77">
          <label>77</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vega</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zaghi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fritz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jindal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Buyuk</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43&#x000a0;years&#x000a0;old: analysis of SART CORS data.</article-title>
            <source>J Assist Reprod Genet</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>35</volume>
            <issue>11</issue>
            <fpage>2025</fpage>
            <page-range>2025-2029</page-range>
            <pub-id pub-id-type="pmid">30128819</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hansen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Styer</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Wild</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Butts</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Engmann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Diamond</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Legro</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Coutifaris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alvero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Casson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Christman</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Santoro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Medicine Network</collab>
            </person-group>
            <article-title>Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination.</article-title>
            <source>Fertil Steril</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>105</volume>
            <issue>6</issue>
            <fpage>1575</fpage>
            <page-range>1575-1583.e2</page-range>
            <pub-id pub-id-type="pmid">26949110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <collab>Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org</collab>
            <collab>Practice Committee of the Society for Assisted Reproductive Technology</collab>
            <article-title>Guidance on the limits to the number&#x000a0;of embryos to transfer: a&#x000a0;committee opinion.</article-title>
            <source>Fertil Steril</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>107</volume>
            <issue>4</issue>
            <fpage>901</fpage>
            <page-range>901-903</page-range>
            <pub-id pub-id-type="pmid">28292618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>WH</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Ping</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xi</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>MX</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for ectopic pregnancy: a multi-center case-control study.</article-title>
            <source>BMC Pregnancy Childbirth</source>
            <year>2015</year>
            <month>Aug</month>
            <day>22</day>
            <volume>15</volume>
            <fpage>187</fpage>
            <pub-id pub-id-type="pmid">26296545</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r81">
          <label>81</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Londra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moreau</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Strobino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zacur</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Ectopic pregnancy after in vitro fertilization: differences between fresh and frozen-thawed cycles.</article-title>
            <source>Fertil Steril</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>104</volume>
            <issue>1</issue>
            <fpage>110</fpage>
            <page-range>110-8</page-range>
            <pub-id pub-id-type="pmid">25956363</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diamond</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Legro</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Coutifaris</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alvero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Casson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Christman</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Ager</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Usadi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Seungdamrong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bates</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Haisenleder</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krawetz</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Barnhart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Trussell</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Ohl</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Santoro</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Eisenberg</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <collab>NICHD Reproductive Medicine Network</collab>
            </person-group>
            <article-title>Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility.</article-title>
            <source>N Engl J Med</source>
            <year>2015</year>
            <month>Sep</month>
            <day>24</day>
            <volume>373</volume>
            <issue>13</issue>
            <fpage>1230</fpage>
            <page-range>1230-40</page-range>
            <pub-id pub-id-type="pmid">26398071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Golan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ron-el</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Herman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Soffer</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Weinraub</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Caspi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Ovarian hyperstimulation syndrome: an update review.</article-title>
            <source>Obstet Gynecol Surv</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>6</issue>
            <fpage>430</fpage>
            <page-range>430-40</page-range>
            <pub-id pub-id-type="pmid">2660037</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23502.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delvigne</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rozenberg</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.</article-title>
            <source>Hum Reprod Update</source>
            <year>2002</year>
            <season>Nov-Dec</season>
            <volume>8</volume>
            <issue>6</issue>
            <fpage>559</fpage>
            <page-range>559-77</page-range>
            <pub-id pub-id-type="pmid">12498425</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
